One of the worst performers on the All Ordinaries index on Thursday has been the BWX Ltd (ASX: BWX) share price.
In afternoon trade the personal care products company’s shares are down 5.5% to $4.37.
Why is the BWX share price dropping lower?
BWX held its annual general meeting in Melbourne on Thursday.
Ahead of the event the company behind the Sukin brand released its presentation, which included its guidance for FY 2020.
Expectations were high for this meeting. So much so, as of Wednesday’s close, the company’s shares had risen a massive 13% since the start of the week to a 52-week high.
Unfortunately for any investors betting on a guidance upgrade, management only reaffirmed its guidance for the full year.
It said: “With a clear strategic direction now established and a strong, company-wide desire to accelerate the natural beauty revolution, we have entered FY20 with solid momentum. This momentum is underscored today as we reaffirm our FY20 guidance provided to the market at our results in August.”
This guidance is for revenue growth of 20% to 25% and EBITDA growth of 25% to 35% in FY 2020.
What else happened at the meeting?
Although BWX’s shares have been market beaters in 2019 with a 163% gain, they have thoroughly underperformed over the last couple of years.
For example, in January 2018 the company’s shares were trading just short of $8.00. Which means anyone that bought in at that level is still nursing a sizeable decline following its disastrous performance in FY 2018 and the first half of FY 2019.
This has clearly not been forgotten by shareholders, who very nearly gave the company’s remuneration report a first strike.
According to its meeting results, 23.97% of votes were cast against the renumeration report. This is just short of the 25% required to issue a first strike.
One company that wasn’t so lucky this month was Ramsay Health Care Limited (ASX: RHC). It received a first strike when 29.23% voted against the private hospital operator’s remuneration report.
The post Why the BWX share price is tumbling lower today appeared first on Motley Fool Australia.
Not sure about BWX? Then check out these growth shares that are simply too cheap to ignore at current levels.
Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
- Man bets $221,666 on one ASX stock
- Top analysts name their top 3 ASX blue chip shares for 2019
- 3 quality dividend shares to boost your income
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- 5 Stocks for Potentially Building Wealth After 50
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended BWX Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019